On August 24, 2010, DePuy (pronounced "DePew") Orthopaedics, Inc., a subsidiary of Johnson & Johnson based in Indiana, issued a global recall of more than 93,000 hip replacement products. The DePuy recall announcement followed only days behind the FDA's issuance of a warning letter to the company concerning its sale of products not approved by the FDA. The recall specifically concerns the:
The DePuy hip replacement devices are known as "metal-on-metal" products. Some reports suggest that, over time, the ball and socket components wear down and release metal debris into the hip joint and adjacent muscle and tendons, causing fluids to accumulate in the joint with damage to the musculature, bones and nerves around the hip. In the worst cases, the implant can loosen and cause the hip to dislocate, or fracture.According to DePuy, approximately 1 in 8 people (12-13%) who received a DePuy hip replacement device with need a "revision" within five (5) years. A "revision" is a second surgery to remove the DePuy device and replace it with a different product. Patients at greatest risk for a revision are:
Since the recall was issued, the Bottar Leone, PLLC legal team has fielded dozens of calls from patients who received components of the ASR hip replacement systems, including:
To discuss your case or concerns with an experienced Central New York DePuy hip recall attorney, contact us now at (315) 422-3466, (800) 336-LAWS, or by e-mail at email@example.com.